-transparent.png){kind=logo}
26 hypertensive patients groupded according to the severity-index and the WHO-index were treated with pindolol (monotherapy, 15 mg daily). The response of blood pressure depression was statistically significant, although not always sufficient when judged by clinical parameters. Plasma renin activity responded variably to the treatment in different patients and different groups. In 18 patients a statistically significant increase of serum potassium could be observed. No major side effects of therapy were encountered.
Related Publications
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
November 1973,
La Nouvelle presse medicale,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
January 1970,
American heart journal,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
November 1962,
Current therapeutic research, clinical and experimental,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
November 1987,
European heart journal,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
February 1979,
The New Zealand medical journal,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
October 1962,
JAMA,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
September 1973,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
January 1992,
Journal of cardiovascular pharmacology,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
December 1963,
American heart journal,
W F Pinggera, and
P Fitscha, and
H K Stummvoll, and
A Wolf, and
P Dorda
June 1962,
Current therapeutic research, clinical and experimental,
